Endonovo Therapeutics Market Cap

Endonovo Therapeutics has a market cap or net worth of $120.66 thousand as of June 26, 2025. Its market cap has decreased by -88.31% in one year.

Market Cap

120.66K

Enterprise Value

7.18M

Revenue

255.72K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since February 20, 2013, Endonovo Therapeutics's market cap has increased from 78.90K to 120.66K, an increase of 52.93%. That is a compound annual growth rate of 3.50%.

Market Cap History

Date	Market Cap	% Change
Jun 25, 2025	120.66K	-44.54%
Dec 31, 2024	217.55K	-92.16%
Dec 29, 2023	2.77M	-20.72%
Dec 30, 2022	3.50M	211.37%
Dec 31, 2021	1.12M	127.79%
Dec 31, 2020	493.17K	-74.11%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Elite Pharmaceuticals	827.70M
Veradigm	764.23M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
American Oncology Network	420.90M
CytoDyn	404.64M
Glass House Brands	389.15M

Market Cap Rankings